Clinical Trials Directory

Trials / Completed

CompletedNCT02893514

Leveraging Technology to Address Unhealthy Drug Use in Primary Care Settings

Leveraging Technology to Address Unhealthy Drug Use in Primary Care: Effectiveness of the Substance Use Screening and Intervention Tool (SUSIT)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
79 (actual)
Sponsor
NYU Langone Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study will develop a clinical decision support tool that assists primary care providers in carrying out substance use interventions, and then compare (in Phase 2) two clinical scenarios, screening only (SO) vs. SUSIT, (on dose of substance use brief intervention received) and changes in drug use at 3 and 6 months, among primary care patients. Investigators will develop the Clinical Decision Support (CDS) component and then test the full SUSIT approach, using mixed methods to assess its acceptability and adoption, and gathering preliminary data on its efficacy for reducing unhealthy drug use. CDS development is concurrent with the SO phase to avoid losing valuable time, but will be conducted at a secondary study site to avoid contaminating the SO condition.

Detailed description

This study has 3 specific aims: Aim 1 is to develop clinical decision support that assists primary care providers in carrying out a brief intervention. Aim 2 is to assess the impact of the SUSIT on dose of substance use brief intervention received by patients. Aim 3 is to gather preliminary evidence on the efficacy of the SUSIT approach for reducing moderate-risk drug use.

Conditions

Interventions

TypeNameDescription
OTHERScreening Only (SO) conditionPatient and PCP are not presented with screening results. The PCP does not receive clinical decision support, or clinical reminders.
OTHERSUSIT ConditionFollowing completion of substance use screening, the tablet computer presents screening results (including level of risk) to the patient for each substance used, asks them to identify their drug of most concern (DOMC), and assesses readiness and confidence to change behavior. Results are delivered to the PCP at the point of care, paired with clinical decision support tailored to the patient's screening results. This information is delivered on the tablet computer, which is handed to the PCP by a Medical Assistant. CDS guides the PCP through a brief intervention specific to the DOMC, recommends clinical actions pertaining to the substance and risk level, and generates a printed summary for the patient. At each scheduled follow-up medical visit, the PCP receives a clinical reminder containing a summary of the patient's substance use and level of risk, paired with CDS that guides them through a follow-up brief intervention.

Timeline

Start date
2017-04-13
Primary completion
2019-03-30
Completion
2019-07-31
First posted
2016-09-08
Last updated
2022-05-09
Results posted
2022-05-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02893514. Inclusion in this directory is not an endorsement.